Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

NextGen Voices: Quality mentoring.

Segal L, Agarwal D, Isaacson KJ, Oehmke TB, Kumar B, Chen JS, Cusimano JM, Negi S, Tiper I, Bakermans AJ, Jensen MM, Sanganyado E, Zaidi SS, Romero-Molina C, Martínez SE, Anderson SM, Santos GM, De Lella Ezcurra AL, Farragher J, Sharma V, Duncan G, Dutton-Regester K, Kim SA, Yu S, Schwendimann BA, Reichardt JKV, Halder A, Dennis AF, Ellwanger JH, Chiu YH, Kerman BE.

Science. 2018 Oct 5;362(6410):22-24. doi: 10.1126/science.aav5914. No abstract available.

PMID:
30287645
2.

Targeted attack: mechanisms by which ovarian cancers suppress the immune system.

Tiper IV, Webb TJ.

Transl Cancer Res. 2016 Nov;5(Suppl 6):S1305-S1306. doi: 10.21037/tcr.2016.11.62. No abstract available.

3.

Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.

Tiper IV, Webb TJ.

Cancer Immunol Immunother. 2016 Nov;65(11):1411-1421. Epub 2016 Sep 10.

4.

Immunotherapeutic strategies targeting natural killer T cell responses in cancer.

Shissler SC, Bollino DR, Tiper IV, Bates JP, Derakhshandeh R, Webb TJ.

Immunogenetics. 2016 Aug;68(8):623-38. doi: 10.1007/s00251-016-0928-8. Epub 2016 Jul 8. Review.

5.

Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.

Tiper IV, East JE, Subrahmanyam PB, Webb TJ.

Pathog Dis. 2016 Aug;74(6). pii: ftw063. doi: 10.1093/femspd/ftw063. Epub 2016 Jun 27. Review.

6.

VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells.

Tiper IV, Temkin SM, Spiegel S, Goldblum SE, Giuntoli RL 2nd, Oelke M, Schneck JP, Webb TJ.

Clin Cancer Res. 2016 Aug 15;22(16):4249-58. doi: 10.1158/1078-0432.CCR-15-2518. Epub 2016 Apr 13.

7.

Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice.

Obata F, Subrahmanyam PB, Vozenilek AE, Hippler LM, Jeffers T, Tongsuk M, Tiper I, Saha P, Jandhyala DM, Kolling GL, Latinovic O, Webb TJ.

Front Microbiol. 2015 Apr 8;6:262. doi: 10.3389/fmicb.2015.00262. eCollection 2015.

8.

NKT Cell Responses to B Cell Lymphoma.

Li J, Sun W, Subrahmanyam PB, Page C, Younger KM, Tiper IV, Frieman M, Kimball AS, Webb TJ.

Med Sci (Basel). 2014 Jun 1;2(2):82-97.

9.

Development of a qPCR method to rapidly assess the function of NKT cells.

Sohn S, Tiper I, Japp E, Sun W, Tkaczuk K, Webb TJ.

J Immunol Methods. 2014 May;407:82-9. doi: 10.1016/j.jim.2014.03.026. Epub 2014 Apr 12.

Supplemental Content

Support Center